Inaktiver Wert

Andere Sprachen Dermira, Inc.

Aktien

A12DEE

US24983L1044

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

QBREXZA Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Payment to Journey Medical Corporation and $7.5 Million to Dermira Inc	11.02.22
Journey Medical Corp completed the acquisition of Qbrexza from Dermira, Inc.	30.04.21
Journey Medical Corp entered into a definitive agreement to acquire Qbrexza from Dermira, Inc. for $160 million.	31.03.21
Evommune, Inc. Enters into an Exclusive License Agreement with Dermira, Inc	07.01.21
Eli Lilly and Company and Dermira Present New Lebrikizumab Phase 2B Clinical Data Showing Patients with Atopic Dermatitis Had Clinically Meaningful Improvements in Itch, Sleep and Quality of Life	12.06.20
Dermira : Form 15-12B - Securities Registration Termination	02.03.20
Dermira : SEC Filing - S-8 POS	20.02.20
Dermira : SEC Filing - POS AM	20.02.20
Dermira, Inc. Announces Board Changes	20.02.20
Dermira : Lilly Completes Acquisition of Dermira	20.02.20
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P Global BMI Index	20.02.20
Dermira, Inc.(NasdaqGS:DERM) dropped from S&P TMI Index	20.02.20
Eli Lilly and Company completed the acquisition of 74.8% stake in Dermira, Inc. from a group of sellers.	19.02.20
Dermira : Statement of Ownership	10.02.20
Dermira : Eli Lilly profit beat helps ease investor concerns over growth	30.01.20
Dermira : Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 - CFO	17.01.20
Eli Lilly and : Lilly Announces Agreement to Acquire Dermira	13.01.20
WeissLaw LLP Investigates Dermira, Inc.	10.01.20
USA: Les valeurs à suivre à Wall Street	10.01.20
DERMIRA, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	10.01.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Dermira, Inc.

Aktien

A12DEE

US24983L1044

Andere Sprachen

Filter